Sun Pharma acquires US-based Pharmalucence

Tags: Companies
Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.

Pharmalucence, which has sterile injectable capacity in the US, has been acquired by one of the subsidiaries of Sun Pharma, the Mumbai-based firm said in a statement today.

The company, however, did not disclose the financial details of the deal.

Earlier this year, Sun Pharma had acquired Ranbaxy Laboratories in an all-stock transaction with a total equity value of $3.2 billion along with debt of $800 million, taking the overall deal value to $4 billion.

Sun Pharma shares were trading at Rs 748.30, up 1.30 per cent from its previous close.

EDITORIAL OF THE DAY

  • In lavishing largesse on bureaucrats, the government may be buying their loyalty

    Wednesday’s pay hike for central government employees continues to strengthen post colonial India’s colonial structures of power, privileges and p

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Urs Schoettli

Brexit from an East Asian point of view

The decision of the Br­itish voters to leave the European ...

Zehra Naqvi

The hawk & the human

Humankind is obsessed with the desire to fly. That’s why ...

Bubbles Sabharwal

A piece of peace

Travel is intoxicating and invigorating, magical and mystical! You never ...